Chemoinformaics analysis of 3,14-Dihydroxycarda-5,20(22)-dienolide
| Molecular Weight | 372.505 | nRot | 1 |
| Heavy Atom Molecular Weight | 340.249 | nRig | 25 |
| Exact Molecular Weight | 372.23 | nRing | 5 |
| Solubility: LogS | -4.805 | nHRing | 1 |
| Solubility: LogP | 3.633 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 62.9554 |
| nHD | 2 | BPOL | 34.7066 |
| QED | 0.634 |
| Synth | 4.693 |
| Natural Product Likeliness | 2.65 |
| NR-PPAR-gamma | 0.512 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.004 |
| HIA | 0.015 |
| CACO-2 | -4.846 |
| MDCK | 0.0000162 |
| BBB | 0.703 |
| PPB | 0.970689 |
| VDSS | 1.47 |
| FU | 0.0361364 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.734 |
| CYP2c19-inh | 0.049 |
| CYP2c19-sub | 0.69 |
| CYP2c9-inh | 0.182 |
| CYP2c9-sub | 0.825 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.822 |
| CYP3a4-inh | 0.189 |
| CYP3a4-sub | 0.228 |
| CL | 18.227 |
| T12 | 0.072 |
| hERG | 0.016 |
| Ames | 0.017 |
| ROA | 0.983 |
| SkinSen | 0.051 |
| Carcinogencity | 0.924 |
| EI | 0.009 |
| Respiratory | 0.936 |
| NR-Aromatase | 0.686 |
| Antiviral | No |
| Prediction | 0.602185 |